Results 181 to 190 of about 53,199 (316)
Beta-adrenergic receptor kinase. Agonist-dependent receptor binding promotes kinase activation.
Ching‐Yu Chen +3 more
openalex +1 more source
Abstract INTRODUCTION Sleep–wake disturbances frequently occur at early stages of Alzheimer's disease (AD) and accelerate disease progression, but the underlying neural mechanisms are not fully understood. METHODS We examined sleep–wake behavior and locus coeruleus (LC) activity in young 5xFAD mice using electrophysiology and pharmacological approaches
Yi‐Ci Zhang +5 more
wiley +1 more source
Trends in first‐line monotherapy and combination therapy for hypertension in UK primary care
Aims Debate remains about the optimal initial treatment strategy for hypertension. Most guidelines recommend first‐line combination therapy for most patients. However, the UK's National Institute for Health and Care Excellence recommends first‐line monotherapy for all patients.
Kyle Johnson +4 more
wiley +1 more source
Β3-Adrenergic Receptors and Prematurity-Related Diseases: A Systematic Review. [PDF]
Fazi C, Dani C.
europepmc +1 more source
The meta‐analysis, involving with 96 patients, shows high overall response rate with favorable safety to use topical beta‐blockers for epidermal growth factor receptor inhibitors‐induced periungual side effects. Subgroups of lung cancer or solution formation had lower complete response rate, while tyrosine kinase inhibitor and female patients had ...
Po‐Kai Chan +2 more
wiley +1 more source
beta-Adrenergic agonist activity of a monoclonal anti-idiotypic antibody.
J G Guillet +5 more
openalex +2 more sources
Neurons, immune cells, and other cellular components within the disease microenvironment (such as stromal cells and tumor cells) constitute a dynamically evolving ecosystem. Neurons directly modulate immune cell activity and inflammatory responses through the release of neurotransmitters (e.g., norepinephrine and CGRP), while also promoting tumor ...
Xin Guo +11 more
wiley +1 more source
The Comparative Effectiveness of PDE5 Inhibitors and β3 Agonists Versus α-Blockers in Medical Expulsive Therapy for Distal Ureteric Stones: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. [PDF]
Ramanah M +5 more
europepmc +1 more source

